BiomimX

MIMETAS

MIMETAS develops organ-on-a-chip tissue models and microfluidic culture plates for pharmaceutical companies to conduct drug discovery, toxicology screening and disease research.

VitrofluidiX

VitrofluidiX develops an integrated organ-on-a-chip platform for pharmaceutical companies and research institutions to conduct predictive human biology testing without animal models.

MISO Chip

This company develops microfluidic tumor-on-a-chip platforms for biopharmaceutical firms and academic researchers to conduct preclinical ex vivo drug testing on human tissue models.

Hooke Bio

This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.

MYLeukaemia

This company develops a bone-marrow-on-a-chip platform for functional precision oncology to test blood cancer drug efficacy for pharmaceutical companies and clinical researchers.

Tissue Dynamics

This company develops sensor-integrated organ-on-chip platforms for pharmaceutical, nutraceutical and cosmetic customers to accelerate drug discovery and safety testing.

Finnadvance

This company develops microfluidic organ-on-chip platforms for pharmaceutical and academic researchers to perform drug testing and mimic human organ functions.

TTOP

TTOP develops modular microphysiological platforms and culture modules for researchers to replicate human biology and conduct predictive in-vitro drug testing and tissue modelling.